Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
ConditionSoft Tissue Lesion
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorGalvanize Therapeutics, Inc.
About this trial
The goal of this observational registry is to assess the use and performance of Galvanize PEF technology in a real-world setting. The main questions it aims to answer are:
* PEF utilization and performance * Monitor safety outcomes and inform future generation devices.
Participants will undergo the PEF procedure and be followed per institutional standard of care.
Eligibility criteria
Qualifiers
Subject will undergo or has undergone PEF energy delivery utilizing Galvanize technology
Subject is expected to be available for follow-up per the enrolling physician's standard care practices
For prospective cohort, subject has a life expectancy of at least 3 months; for retrospective cohort, subject has completed at least three months of imaging following the PEF procedure
Signed informed consent is obtained, if required by IRB
Disqualifiers
None
Trial design
Treatments tested in this trial
- PEF ablation
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov